Prevalence of microalbuminuria among sudanese type 2 diabetic patients at elmusbah center at ombadda - omdurman

@article{Rahamtalla2012PrevalenceOM,
  title={Prevalence of microalbuminuria among sudanese type 2 diabetic patients at elmusbah center at ombadda - omdurman},
  author={Fayza Ahmed Rahamtalla},
  journal={IOSR Journal of Pharmacy},
  year={2012},
  volume={2},
  pages={51-55}
}
–Microalbuminuria is persistent albumin excretion between 30 and 300 mg/day, in patients with diabetes it is usually indicative of diabetic nephropathy which is most common cause of end stage renal disease, it is also associated with cardiovascular disease. Early detection of microalbuminuria and early control of diabetes retards the development of structural changes in early diabetic nephropathy. The main objective was to determine the prevalence of microalbuminuria on urine samples of… 

Tables from this paper

Prevalence of Proteinuria among Type 2 Diabetic Patients in Dhamar Governorate, Yemen

Screening for TPCR and estimation of microalbuminuria allow early identification of nephropathy which help in implementing effective interventions to manage the risk factors and prevent the serious diabetic complications.

Prevalence of Microalbuminuria and Associated Factors Among Type 2 Diabetes Mellitus Patients in Jigjiga Town Public Hospitals, Somali Regional State, Ethiopia, 2020

There is a significant level of micro-albuminuria among type 2 diabetes mellitus patients and effective secondary prevention program directed on blood glucose and lipid with steps to improve blood pressure are critical in undertaking in the setting.

Prevalence and Associated Factors of Diabetic Kidney Disease in Senegalese Patients: A Cross-Sectional Study in Saint-Louis

DKD is a frequent complication in diabetic adult population living in Saint-Louis and early detection and management should be promoted in order to prevent progression to end-stage renal disease.

Prevalence of diabetic kidney disease in patients with type 2 diabetes mellitus

The prevalence of DN is increasing, partly due to the growing epidemic of type 2 diabetes so it has to detect it as early as possible to apply the proper measures to prevent or delay its progression.

Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries

Diabetic nephropathy (DN), which is characterized by proteinuria, is one of the most serious long-term microvascular complications of DM, and the proportion of DN is increasing worldwide.

Screening for Nephropathy in Diabetes Mellitus: Is Micral-Test Valid among All Diabetics?

The use of Micral-test in primary healthcare for yearly screening for MA in T2D must be accentuated especially when diabetes duration exceeds 5 years or when associated with other cardiovascular risks.

Diabetic nephropathy and hypertension in diabetes patients of sub-Saharan countries: a systematic review and meta-analysis

An increased risk of diabetic nephropathy with hypertension compared to without hypertension was revealed and a preventive strategy should be adopted or planned to reduce diabetes mellitus and its complication of neuropathy, particularly in hypertensive patients.

Effects of short-term malnutrition in rats

The data suggest that short-term malnutrition is able to induce a malnutrition condition and signs of liver alteration, but it does not cause generalized biochemical and hematological changes.

DÉFICIT NUTRICIONAL EM RATOS WISTAR

A desnutrição causa diversos tipos de alterações, síndromes e doenças, afetando de forma generalizada ou não, vários parâmetros do indivíduo. Diante disso, o presente estudo objetivou avaliar os

References

SHOWING 1-10 OF 33 REFERENCES

Prevalence of Microalbuminuria in Older-Onset Diabetes

Findings suggest a relationship between controllable risk factors, blood pressure and GHb, and microalbuminuria in older-onset diabetic individuals.

Diabetic nephropathy: diagnosis, prevention, and treatment.

Treating hypertension, using drugs with blockade effect on the renin-angiotensin-aldosterone system, and treating dyslipidemia are effective strategies for preventing the development of microalbuminuria, in delaying the progression to more advanced stages of nephropathy and in reducing cardiovascular mortality in patients with type 1 and type 2 diabetes.

A Prospective Population-Based Study of Microalbuminuria as a Predictor of Mortality in NIDDM

Objective— To assess prospectively the relationship between microalbuminuria and mortality in a geographically defined population of NIDDM patients and to determine the relative importance of

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

Relatively fewer patients with type 2 diabetes develop macroalbuminuria, but in those who do, the death rate exceeds the rate of progression to worse nephropathy, and risk of death from all-causes or cardiovascular disease is high.

Microalbuminuria and cardiovascular disease.

  • M. Weir
  • Medicine
    Clinical journal of the American Society of Nephrology : CJASN
  • 2007
A positive test for urinary albumin excretion could signify the need for an intensive multifactorial intervention strategy, including behavior modification and targeted pharmacotherapy, aimed at preventing further renal deterioration and improving the overall CVD risk factor profile.

Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men.

The association of increased albuminuria with wider pulse pressure, a correlate of the pulsatile hemodynamic load and conduit vessel stiffness as well as an important cardiovascular risk factor, may explain why microalbuminuria predicts cardiovascular events in nondiabetic subjects.

Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes.

It is concluded that cigarette smoking is an independent risk factor and is associated with the development and progression of early diabetic renal damage (albuminuria) and with the worsening of retinal disease in young subjects with diabetes.

Slowing Progression Along the Renal Disease Continuum

  • N. Kopyt
  • Medicine, Biology
    The Journal of the American Osteopathic Association
  • 2005
Clinical trials show reduced cardiovascular risk and a reversal of microalbuminuria with the use of agents that affect the renin-angiotensin system: angiotens in-receptor blockers in patients with type 2 diabetes mellitus and nephropathy, or ang Elliotensin-converting enzyme inhibitors in Patients with type 1 Diabetes mellitus.

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Intensive diabetes therapy has long-term beneficial effects on the risk of cardiovascular disease in patients with type 1 diabetes, and changes between treatment groups remained significant after adjusting for these factors.